SyntekaBio, Inc. (KOSDAQ:226330)
South Korea flag South Korea · Delayed Price · Currency is KRW
1,822.00
-129.00 (-6.61%)
At close: Jun 18, 2026

SyntekaBio Ratios and Metrics

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
44,34459,43280,107216,882115,982241,650
Market Cap Growth
-60.73%-25.81%-63.06%87.00%-52.00%-21.37%
Enterprise Value
38,74470,19571,044189,59186,513-
Last Close Price
1828.003895.004388.7911904.077172.5414963.68
PS Ratio
14.8717.33662.661757.47475.35763.13
PB Ratio
1.561.873.216.953.698.75
P/TBV Ratio
1.581.893.277.053.768.89
EV/Sales Ratio
12.9920.47587.691536.32354.57-
Debt / Equity Ratio
0.280.220.290.070.350.32
Net Debt / Equity Ratio
-0.20-0.29-0.19-0.56-0.77-1.59
Net Debt / EBITDA Ratio
0.601.060.401.672.355.67
Net Debt / FCF Ratio
0.530.870.291.011.433.25
Asset Turnover
0.070.080.000.000.000.01
Quick Ratio
1.121.410.741.021.5928.00
Current Ratio
1.161.420.771.131.6930.82
Return on Equity (ROE)
-58.95%-61.27%-25.68%-36.36%-15.25%-42.80%
Return on Assets (ROA)
-16.34%-14.91%-18.46%-14.13%-11.93%-9.87%
Return on Capital Employed (ROCE)
-36.70%-31.40%-52.10%-36.60%-35.30%-13.50%
Earnings Yield
-30.62%-29.24%-9.00%-5.25%-3.89%-6.13%
FCF Yield
-23.77%-17.94%-20.24%-8.04%-14.57%-5.59%
Buyback Yield / Dilution
-16.88%-2.16%-6.52%-5.94%-0.37%-1.65%